| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 28 | 2025 | 456 | 6.630 |
Why?
|
| Smith-Magenis Syndrome | 18 | 2022 | 105 | 4.930 |
Why?
|
| Intellectual Disability | 39 | 2025 | 1078 | 4.610 |
Why?
|
| Metabolism, Inborn Errors | 9 | 2024 | 121 | 3.350 |
Why?
|
| Abnormalities, Multiple | 26 | 2021 | 976 | 3.250 |
Why?
|
| Chromosomes, Human, Pair 17 | 26 | 2016 | 374 | 3.140 |
Why?
|
| Trans-Activators | 24 | 2016 | 830 | 2.410 |
Why?
|
| Developmental Disabilities | 11 | 2024 | 733 | 2.340 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 7 | 2024 | 115 | 2.320 |
Why?
|
| Chromosome Deletion | 19 | 2021 | 664 | 2.130 |
Why?
|
| Metabolome | 13 | 2024 | 312 | 2.070 |
Why?
|
| Phenotype | 43 | 2025 | 4551 | 1.950 |
Why?
|
| Neurodevelopmental Disorders | 7 | 2025 | 529 | 1.920 |
Why?
|
| Transcription Factors | 23 | 2023 | 2712 | 1.850 |
Why?
|
| DNA-Binding Proteins | 13 | 2023 | 2164 | 1.740 |
Why?
|
| Biomarkers | 12 | 2021 | 3430 | 1.620 |
Why?
|
| Haploinsufficiency | 8 | 2016 | 274 | 1.600 |
Why?
|
| Exome | 5 | 2023 | 1068 | 1.550 |
Why?
|
| Chromosomes, Human, Pair 2 | 8 | 2021 | 123 | 1.420 |
Why?
|
| Mutation | 37 | 2025 | 6294 | 1.410 |
Why?
|
| Mitochondrial Diseases | 6 | 2025 | 149 | 1.340 |
Why?
|
| Autism Spectrum Disorder | 8 | 2025 | 422 | 1.300 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 4 | 2023 | 17 | 1.280 |
Why?
|
| Craniofacial Abnormalities | 10 | 2021 | 250 | 1.200 |
Why?
|
| Metabolic Networks and Pathways | 8 | 2024 | 197 | 1.200 |
Why?
|
| Metabolic Diseases | 4 | 2022 | 139 | 1.170 |
Why?
|
| Sleep Wake Disorders | 4 | 2021 | 187 | 1.170 |
Why?
|
| Syndrome | 26 | 2015 | 1159 | 1.150 |
Why?
|
| Child, Preschool | 43 | 2024 | 14805 | 1.130 |
Why?
|
| Humans | 152 | 2025 | 133705 | 1.130 |
Why?
|
| Circadian Rhythm | 3 | 2015 | 297 | 1.100 |
Why?
|
| Histone Deacetylases | 4 | 2019 | 123 | 1.090 |
Why?
|
| Succinate-Semialdehyde Dehydrogenase | 2 | 2024 | 2 | 0.980 |
Why?
|
| Child | 51 | 2024 | 25765 | 0.970 |
Why?
|
| Microcephaly | 4 | 2024 | 347 | 0.970 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 3 | 2020 | 39 | 0.940 |
Why?
|
| Male | 80 | 2024 | 65850 | 0.940 |
Why?
|
| Genotype | 12 | 2023 | 2805 | 0.940 |
Why?
|
| Female | 77 | 2025 | 71603 | 0.920 |
Why?
|
| Infant | 31 | 2025 | 13173 | 0.900 |
Why?
|
| Urea Cycle Disorders, Inborn | 3 | 2023 | 85 | 0.890 |
Why?
|
| Hyperventilation | 2 | 2021 | 14 | 0.890 |
Why?
|
| Child Development Disorders, Pervasive | 4 | 2015 | 82 | 0.870 |
Why?
|
| Repressor Proteins | 5 | 2019 | 868 | 0.860 |
Why?
|
| Hyperphagia | 3 | 2022 | 46 | 0.860 |
Why?
|
| Adolescent | 38 | 2025 | 20520 | 0.820 |
Why?
|
| Chromatography, Liquid | 4 | 2020 | 243 | 0.820 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2023 | 9 | 0.820 |
Why?
|
| Muscle Hypotonia | 3 | 2024 | 196 | 0.820 |
Why?
|
| Racemases and Epimerases | 1 | 2022 | 11 | 0.770 |
Why?
|
| NADP | 1 | 2022 | 55 | 0.770 |
Why?
|
| NAD | 1 | 2022 | 49 | 0.760 |
Why?
|
| Niacin | 1 | 2022 | 59 | 0.760 |
Why?
|
| Phenylbutyrates | 2 | 2023 | 58 | 0.740 |
Why?
|
| Neonatal Screening | 3 | 2025 | 193 | 0.720 |
Why?
|
| Gene Deletion | 8 | 2016 | 809 | 0.710 |
Why?
|
| Genetic Association Studies | 4 | 2019 | 847 | 0.710 |
Why?
|
| Hand Deformities, Congenital | 3 | 2020 | 95 | 0.700 |
Why?
|
| Transaldolase | 1 | 2020 | 4 | 0.690 |
Why?
|
| Transketolase | 1 | 2020 | 19 | 0.690 |
Why?
|
| Farber Lipogranulomatosis | 1 | 2020 | 1 | 0.690 |
Why?
|
| Acid Ceramidase | 1 | 2020 | 7 | 0.680 |
Why?
|
| Dopa Decarboxylase | 2 | 2022 | 7 | 0.680 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2020 | 13 | 0.680 |
Why?
|
| Penetrance | 2 | 2019 | 111 | 0.670 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2020 | 45 | 0.660 |
Why?
|
| Self-Injurious Behavior | 4 | 2015 | 65 | 0.640 |
Why?
|
| Wolman Disease | 1 | 2019 | 7 | 0.620 |
Why?
|
| Sterol Esterase | 1 | 2019 | 20 | 0.620 |
Why?
|
| Proteins | 4 | 2006 | 1093 | 0.620 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2019 | 17 | 0.620 |
Why?
|
| Seizures | 7 | 2024 | 889 | 0.610 |
Why?
|
| Chromosome Aberrations | 5 | 2016 | 626 | 0.610 |
Why?
|
| Obesity | 7 | 2024 | 2431 | 0.600 |
Why?
|
| Genetic Testing | 6 | 2025 | 1094 | 0.580 |
Why?
|
| Genetic Variation | 3 | 2022 | 1621 | 0.570 |
Why?
|
| Zellweger Syndrome | 1 | 2018 | 16 | 0.570 |
Why?
|
| Peroxisomal Disorders | 1 | 2018 | 18 | 0.560 |
Why?
|
| Adult | 30 | 2025 | 31872 | 0.560 |
Why?
|
| Phenylacetates | 1 | 2017 | 22 | 0.560 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2017 | 43 | 0.560 |
Why?
|
| Carbidopa | 1 | 2017 | 17 | 0.560 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2018 | 37 | 0.560 |
Why?
|
| Mass Spectrometry | 5 | 2020 | 371 | 0.560 |
Why?
|
| Diet, Ketogenic | 1 | 2017 | 24 | 0.550 |
Why?
|
| Glutamine | 2 | 2022 | 222 | 0.550 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2017 | 22 | 0.550 |
Why?
|
| Aggression | 2 | 2019 | 231 | 0.550 |
Why?
|
| Young Adult | 15 | 2024 | 9873 | 0.540 |
Why?
|
| Levodopa | 1 | 2017 | 92 | 0.530 |
Why?
|
| Dopamine Agonists | 1 | 2017 | 80 | 0.530 |
Why?
|
| Pyrroline Carboxylate Reductases | 1 | 2016 | 6 | 0.530 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2016 | 19 | 0.530 |
Why?
|
| Cerebrospinal Fluid | 1 | 2017 | 99 | 0.530 |
Why?
|
| Anemia, Sickle Cell | 1 | 2020 | 342 | 0.530 |
Why?
|
| Genetic Counseling | 1 | 2017 | 245 | 0.500 |
Why?
|
| Homozygote | 2 | 2020 | 561 | 0.490 |
Why?
|
| Fluoroquinolones | 6 | 1997 | 97 | 0.490 |
Why?
|
| Quinolones | 6 | 1997 | 57 | 0.480 |
Why?
|
| Mass Screening | 1 | 2021 | 836 | 0.470 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 648 | 0.470 |
Why?
|
| Problem Behavior | 1 | 2015 | 41 | 0.460 |
Why?
|
| Liver | 3 | 2019 | 1878 | 0.460 |
Why?
|
| Down Syndrome | 1 | 2017 | 231 | 0.460 |
Why?
|
| Period Circadian Proteins | 1 | 2014 | 31 | 0.460 |
Why?
|
| Prader-Willi Syndrome | 1 | 2015 | 69 | 0.460 |
Why?
|
| Leigh Disease | 3 | 2019 | 24 | 0.460 |
Why?
|
| Body Fat Distribution | 2 | 2014 | 31 | 0.450 |
Why?
|
| Cohort Studies | 8 | 2023 | 5194 | 0.450 |
Why?
|
| Polymerase Chain Reaction | 6 | 2013 | 1624 | 0.450 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 904 | 0.440 |
Why?
|
| Frameshift Mutation | 4 | 2010 | 199 | 0.440 |
Why?
|
| Mental Disorders | 3 | 2012 | 886 | 0.430 |
Why?
|
| Autistic Disorder | 4 | 2021 | 366 | 0.430 |
Why?
|
| Dietary Carbohydrates | 1 | 2014 | 117 | 0.430 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2025 | 453 | 0.420 |
Why?
|
| Diet, High-Fat | 2 | 2014 | 237 | 0.420 |
Why?
|
| In Situ Hybridization, Fluorescence | 9 | 2022 | 791 | 0.420 |
Why?
|
| Spasms, Infantile | 3 | 2022 | 175 | 0.410 |
Why?
|
| DNA Topoisomerases, Type II | 5 | 1997 | 25 | 0.410 |
Why?
|
| Anti-Infective Agents | 6 | 1997 | 277 | 0.400 |
Why?
|
| Trisomy | 1 | 2013 | 112 | 0.400 |
Why?
|
| Sibling Relations | 1 | 2012 | 12 | 0.390 |
Why?
|
| Hemochromatosis | 2 | 2005 | 38 | 0.390 |
Why?
|
| Gene Regulatory Networks | 3 | 2020 | 397 | 0.390 |
Why?
|
| Child Development | 1 | 2015 | 286 | 0.390 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2005 | 113 | 0.380 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2019 | 3479 | 0.380 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 1339 | 0.380 |
Why?
|
| Mitochondrial Encephalomyopathies | 2 | 2023 | 29 | 0.370 |
Why?
|
| Pedigree | 7 | 2025 | 1695 | 0.370 |
Why?
|
| Alleles | 7 | 2025 | 1709 | 0.370 |
Why?
|
| Disease Models, Animal | 8 | 2018 | 4793 | 0.370 |
Why?
|
| Animals | 32 | 2023 | 36421 | 0.370 |
Why?
|
| Quality of Life | 2 | 2020 | 2149 | 0.360 |
Why?
|
| Siblings | 1 | 2012 | 198 | 0.360 |
Why?
|
| Veterans | 1 | 2023 | 1779 | 0.360 |
Why?
|
| Gene Dosage | 5 | 2013 | 456 | 0.360 |
Why?
|
| Symporters | 2 | 2025 | 76 | 0.350 |
Why?
|
| Heart Failure | 1 | 2024 | 2424 | 0.350 |
Why?
|
| Haploidy | 1 | 2010 | 21 | 0.350 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2014 | 122 | 0.340 |
Why?
|
| Caregivers | 2 | 2020 | 586 | 0.340 |
Why?
|
| Membrane Proteins | 4 | 2023 | 1604 | 0.340 |
Why?
|
| Muscular Diseases | 3 | 2015 | 117 | 0.340 |
Why?
|
| Behavior | 1 | 2010 | 75 | 0.340 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 2 | 2021 | 22 | 0.330 |
Why?
|
| Molecular Sequence Data | 13 | 2010 | 3971 | 0.330 |
Why?
|
| Purpura | 2 | 2021 | 26 | 0.330 |
Why?
|
| Mice | 19 | 2023 | 18948 | 0.330 |
Why?
|
| Chromosome Mapping | 8 | 2001 | 1123 | 0.320 |
Why?
|
| Feeding Behavior | 1 | 2015 | 731 | 0.320 |
Why?
|
| Infant, Newborn | 14 | 2025 | 8589 | 0.320 |
Why?
|
| Speech Disorders | 1 | 2009 | 49 | 0.320 |
Why?
|
| Haplotypes | 2 | 2009 | 560 | 0.320 |
Why?
|
| Tandem Mass Spectrometry | 5 | 2020 | 292 | 0.310 |
Why?
|
| Sleep | 3 | 2021 | 369 | 0.310 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2008 | 30 | 0.300 |
Why?
|
| Maternal Behavior | 1 | 2009 | 71 | 0.300 |
Why?
|
| Amino Acid Sequence | 9 | 2017 | 2789 | 0.290 |
Why?
|
| Genome, Human | 5 | 2019 | 1348 | 0.290 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 2655 | 0.290 |
Why?
|
| Heterozygote | 5 | 2019 | 720 | 0.290 |
Why?
|
| Gene Expression | 4 | 2021 | 1616 | 0.290 |
Why?
|
| Serotonin | 1 | 2009 | 226 | 0.280 |
Why?
|
| Melatonin | 2 | 2020 | 30 | 0.280 |
Why?
|
| Stereotyped Behavior | 2 | 2019 | 38 | 0.280 |
Why?
|
| Mice, Transgenic | 6 | 2012 | 2529 | 0.280 |
Why?
|
| Urea | 2 | 2019 | 238 | 0.270 |
Why?
|
| Comparative Genomic Hybridization | 5 | 2013 | 577 | 0.270 |
Why?
|
| Social Behavior | 1 | 2009 | 230 | 0.270 |
Why?
|
| Neoplasms, Experimental | 1 | 2008 | 224 | 0.270 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2015 | 2936 | 0.270 |
Why?
|
| Base Sequence | 11 | 2013 | 3172 | 0.270 |
Why?
|
| Moyamoya Disease | 1 | 2007 | 42 | 0.260 |
Why?
|
| Carnitine | 3 | 2015 | 77 | 0.260 |
Why?
|
| Retrospective Studies | 9 | 2024 | 17421 | 0.260 |
Why?
|
| Mothers | 1 | 2010 | 369 | 0.260 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1756 | 0.260 |
Why?
|
| Facies | 3 | 2021 | 154 | 0.260 |
Why?
|
| Schizophrenia | 1 | 2009 | 332 | 0.260 |
Why?
|
| Polymorphism, Genetic | 3 | 2013 | 897 | 0.250 |
Why?
|
| Point Mutation | 4 | 2007 | 360 | 0.250 |
Why?
|
| DNA Mutational Analysis | 4 | 2016 | 839 | 0.250 |
Why?
|
| Growth Disorders | 1 | 2008 | 223 | 0.250 |
Why?
|
| Mice, Knockout | 6 | 2020 | 3991 | 0.250 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 2 | 2015 | 14 | 0.250 |
Why?
|
| Epilepsy | 2 | 2025 | 892 | 0.250 |
Why?
|
| Lipid Metabolism, Inborn Errors | 2 | 2015 | 23 | 0.240 |
Why?
|
| Brain | 8 | 2022 | 3225 | 0.240 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2015 | 1071 | 0.240 |
Why?
|
| Foot Deformities, Congenital | 1 | 2005 | 16 | 0.240 |
Why?
|
| Gene Editing | 2 | 2018 | 213 | 0.230 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2025 | 93 | 0.230 |
Why?
|
| Glutarates | 1 | 2024 | 38 | 0.230 |
Why?
|
| Tyrosine | 2 | 2015 | 159 | 0.230 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2025 | 109 | 0.230 |
Why?
|
| CRISPR-Cas Systems | 2 | 2018 | 295 | 0.230 |
Why?
|
| alpha-MSH | 1 | 2024 | 17 | 0.230 |
Why?
|
| Carrier Proteins | 2 | 2020 | 1067 | 0.230 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 516 | 0.230 |
Why?
|
| Stress, Psychological | 1 | 2010 | 601 | 0.230 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2024 | 28 | 0.220 |
Why?
|
| Cerebellar Diseases | 1 | 2025 | 81 | 0.220 |
Why?
|
| Child Behavior Disorders | 1 | 2005 | 70 | 0.220 |
Why?
|
| Aged | 5 | 2024 | 21674 | 0.220 |
Why?
|
| Arginine-tRNA Ligase | 1 | 2024 | 9 | 0.220 |
Why?
|
| Loss of Function Mutation | 1 | 2025 | 160 | 0.220 |
Why?
|
| Stroke | 2 | 2023 | 1074 | 0.220 |
Why?
|
| DNA Copy Number Variations | 4 | 2016 | 1021 | 0.210 |
Why?
|
| Acidosis, Lactic | 1 | 2023 | 30 | 0.210 |
Why?
|
| MELAS Syndrome | 1 | 2023 | 33 | 0.210 |
Why?
|
| Middle Aged | 6 | 2024 | 29293 | 0.210 |
Why?
|
| Limit of Detection | 3 | 2018 | 77 | 0.210 |
Why?
|
| Prevalence | 4 | 2023 | 2667 | 0.200 |
Why?
|
| Case-Control Studies | 5 | 2015 | 3649 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 6 | 2015 | 4841 | 0.200 |
Why?
|
| Saccharomyces cerevisiae | 3 | 1995 | 440 | 0.200 |
Why?
|
| Uncertainty | 1 | 2023 | 104 | 0.190 |
Why?
|
| Chromosome Disorders | 3 | 2013 | 315 | 0.190 |
Why?
|
| Genetic Carrier Screening | 2 | 2015 | 72 | 0.190 |
Why?
|
| Apyrase | 1 | 2022 | 20 | 0.190 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 21 | 0.190 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 29 | 0.190 |
Why?
|
| Epileptic Syndromes | 1 | 2022 | 32 | 0.190 |
Why?
|
| Sequence Alignment | 2 | 2017 | 631 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2022 | 64 | 0.190 |
Why?
|
| Fibroblasts | 3 | 2019 | 921 | 0.190 |
Why?
|
| Anti-Anxiety Agents | 1 | 2022 | 77 | 0.180 |
Why?
|
| Anemia, Sideroblastic | 1 | 2021 | 17 | 0.180 |
Why?
|
| Epilepsy, Generalized | 1 | 2022 | 65 | 0.180 |
Why?
|
| Loss of Heterozygosity | 1 | 2021 | 135 | 0.180 |
Why?
|
| Cholesterol, HDL | 2 | 2022 | 395 | 0.180 |
Why?
|
| Information Theory | 1 | 2021 | 4 | 0.180 |
Why?
|
| Grenada | 1 | 2020 | 2 | 0.180 |
Why?
|
| DNA Topoisomerases, Type I | 2 | 1998 | 23 | 0.180 |
Why?
|
| Internationality | 1 | 2021 | 138 | 0.170 |
Why?
|
| Anemia, Macrocytic | 1 | 2020 | 8 | 0.170 |
Why?
|
| Bulbar Palsy, Progressive | 1 | 2020 | 8 | 0.170 |
Why?
|
| Riboflavin Deficiency | 1 | 2020 | 9 | 0.170 |
Why?
|
| Amino Acid Substitution | 2 | 2016 | 412 | 0.170 |
Why?
|
| Riboflavin | 1 | 2020 | 34 | 0.170 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2020 | 44 | 0.170 |
Why?
|
| Liver Transplantation | 2 | 2020 | 1128 | 0.170 |
Why?
|
| Topoisomerase II Inhibitors | 4 | 1995 | 15 | 0.170 |
Why?
|
| Dopamine | 2 | 2023 | 284 | 0.170 |
Why?
|
| Thymidine Phosphorylase | 1 | 2020 | 13 | 0.170 |
Why?
|
| De Lange Syndrome | 1 | 2020 | 45 | 0.170 |
Why?
|
| Molecular Sequence Annotation | 1 | 2020 | 162 | 0.170 |
Why?
|
| Cells, Cultured | 6 | 2015 | 3173 | 0.160 |
Why?
|
| Histidine | 2 | 2022 | 75 | 0.160 |
Why?
|
| Pierre Robin Syndrome | 1 | 2020 | 32 | 0.160 |
Why?
|
| Aspirin | 1 | 2021 | 231 | 0.160 |
Why?
|
| Serine | 2 | 2017 | 185 | 0.160 |
Why?
|
| White Matter | 1 | 2022 | 210 | 0.160 |
Why?
|
| Genetic Pleiotropy | 1 | 2019 | 26 | 0.160 |
Why?
|
| Somnambulism | 1 | 2019 | 3 | 0.160 |
Why?
|
| Rare Diseases | 1 | 2021 | 206 | 0.160 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2019 | 6 | 0.160 |
Why?
|
| Dynamins | 1 | 2019 | 43 | 0.160 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 1917 | 0.160 |
Why?
|
| Hybrid Cells | 4 | 2000 | 79 | 0.150 |
Why?
|
| GTP-Binding Proteins | 1 | 2000 | 188 | 0.150 |
Why?
|
| Psychopathology | 1 | 2019 | 34 | 0.150 |
Why?
|
| Pre-Eclampsia | 1 | 2021 | 226 | 0.150 |
Why?
|
| Cell Line | 3 | 2016 | 2841 | 0.150 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2020 | 157 | 0.150 |
Why?
|
| HLA Antigens | 1 | 2000 | 253 | 0.150 |
Why?
|
| INDEL Mutation | 1 | 2019 | 94 | 0.150 |
Why?
|
| Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2018 | 5 | 0.150 |
Why?
|
| Sulfite Oxidase | 1 | 2018 | 4 | 0.150 |
Why?
|
| Molybdenum | 1 | 2018 | 16 | 0.150 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3743 | 0.150 |
Why?
|
| Genetic Linkage | 1 | 2000 | 480 | 0.150 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 714 | 0.150 |
Why?
|
| Arginine | 2 | 2023 | 350 | 0.150 |
Why?
|
| Sphingomyelins | 1 | 2018 | 15 | 0.150 |
Why?
|
| Genes, Recessive | 1 | 2019 | 194 | 0.150 |
Why?
|
| Acyltransferases | 1 | 2018 | 47 | 0.150 |
Why?
|
| Hyperammonemia | 2 | 2015 | 62 | 0.140 |
Why?
|
| Aorta, Thoracic | 1 | 2023 | 538 | 0.140 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2020 | 165 | 0.140 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2017 | 6 | 0.140 |
Why?
|
| Genetic Services | 1 | 2017 | 8 | 0.140 |
Why?
|
| Argininosuccinate Lyase | 1 | 2018 | 65 | 0.140 |
Why?
|
| Gene Duplication | 2 | 2011 | 371 | 0.140 |
Why?
|
| Restriction Mapping | 1 | 1998 | 192 | 0.140 |
Why?
|
| Protein Kinases | 1 | 1999 | 344 | 0.140 |
Why?
|
| Psychomotor Disorders | 1 | 2017 | 29 | 0.140 |
Why?
|
| Phosphatidylcholines | 1 | 2017 | 39 | 0.140 |
Why?
|
| Adaptation, Psychological | 2 | 2012 | 449 | 0.140 |
Why?
|
| Urinalysis | 1 | 2018 | 66 | 0.140 |
Why?
|
| Body Weight | 3 | 2024 | 1037 | 0.140 |
Why?
|
| Transaminases | 1 | 2017 | 36 | 0.140 |
Why?
|
| Vanilmandelic Acid | 1 | 2017 | 8 | 0.140 |
Why?
|
| Edetic Acid | 1 | 2017 | 25 | 0.140 |
Why?
|
| Mitochondria | 2 | 2020 | 744 | 0.140 |
Why?
|
| RNA, Messenger | 4 | 2014 | 2898 | 0.140 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2017 | 34 | 0.140 |
Why?
|
| Radiation Tolerance | 1 | 1998 | 67 | 0.140 |
Why?
|
| Dihydropteridine Reductase | 1 | 2017 | 5 | 0.140 |
Why?
|
| Cysteine | 1 | 2018 | 143 | 0.140 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 407 | 0.140 |
Why?
|
| Ammonia | 1 | 2017 | 77 | 0.140 |
Why?
|
| Glycerol | 1 | 2017 | 99 | 0.140 |
Why?
|
| Argininosuccinic Aciduria | 1 | 2017 | 56 | 0.140 |
Why?
|
| Citric Acid Cycle | 1 | 2017 | 49 | 0.140 |
Why?
|
| Overweight | 2 | 2022 | 385 | 0.140 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 484 | 0.130 |
Why?
|
| DNA, Superhelical | 1 | 1997 | 21 | 0.130 |
Why?
|
| Growth Charts | 1 | 2016 | 15 | 0.130 |
Why?
|
| Translocation, Genetic | 3 | 2022 | 362 | 0.130 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 773 | 0.130 |
Why?
|
| Tyrosinemias | 1 | 2016 | 7 | 0.130 |
Why?
|
| Codon | 1 | 2016 | 108 | 0.130 |
Why?
|
| Glycine | 1 | 2017 | 171 | 0.130 |
Why?
|
| Dietary Supplements | 2 | 2017 | 486 | 0.130 |
Why?
|
| Genomics | 1 | 2025 | 1672 | 0.130 |
Why?
|
| Blood Specimen Collection | 1 | 2017 | 49 | 0.130 |
Why?
|
| Autophagy | 1 | 2020 | 423 | 0.130 |
Why?
|
| Actins | 1 | 1999 | 350 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2021 | 1243 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2021 | 3843 | 0.130 |
Why?
|
| Exons | 4 | 2016 | 833 | 0.130 |
Why?
|
| Algorithms | 2 | 2021 | 1733 | 0.130 |
Why?
|
| Blood Chemical Analysis | 1 | 2016 | 88 | 0.130 |
Why?
|
| Drug Combinations | 1 | 2017 | 284 | 0.130 |
Why?
|
| Brain Diseases | 1 | 2019 | 310 | 0.130 |
Why?
|
| Methionine | 1 | 2016 | 105 | 0.130 |
Why?
|
| Homocysteine | 1 | 2016 | 120 | 0.130 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 1995 | 6 | 0.130 |
Why?
|
| Myelin Proteins | 1 | 2016 | 79 | 0.130 |
Why?
|
| Erythrocytes | 1 | 2017 | 237 | 0.120 |
Why?
|
| Protein Array Analysis | 1 | 2016 | 107 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 1327 | 0.120 |
Why?
|
| Disease Progression | 2 | 2020 | 2239 | 0.120 |
Why?
|
| Hyperargininemia | 1 | 2015 | 13 | 0.120 |
Why?
|
| Whole Genome Sequencing | 1 | 2017 | 327 | 0.120 |
Why?
|
| Behavior, Animal | 2 | 2009 | 521 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2016 | 123 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 716 | 0.120 |
Why?
|
| Dihydroxyphenylalanine | 1 | 2015 | 8 | 0.120 |
Why?
|
| Arginase | 1 | 2015 | 35 | 0.120 |
Why?
|
| Obesity Hypoventilation Syndrome | 1 | 2015 | 4 | 0.120 |
Why?
|
| Cell Cycle | 1 | 1998 | 626 | 0.120 |
Why?
|
| Ellipticines | 1 | 1995 | 1 | 0.120 |
Why?
|
| Social Support | 1 | 2017 | 378 | 0.120 |
Why?
|
| Acetylserotonin O-Methyltransferase | 1 | 2015 | 1 | 0.120 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2015 | 41 | 0.120 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 3032 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2017 | 371 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 5 | 2015 | 1834 | 0.120 |
Why?
|
| Cryptochromes | 1 | 2014 | 7 | 0.120 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2017 | 214 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 473 | 0.120 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2015 | 49 | 0.110 |
Why?
|
| Hypothalamic Diseases | 1 | 2015 | 38 | 0.110 |
Why?
|
| Signal Transduction | 3 | 2021 | 4908 | 0.110 |
Why?
|
| Blotting, Southern | 2 | 2008 | 221 | 0.110 |
Why?
|
| Family | 1 | 2017 | 589 | 0.110 |
Why?
|
| DNA | 4 | 2006 | 1677 | 0.110 |
Why?
|
| Citrullinemia | 1 | 2014 | 15 | 0.110 |
Why?
|
| Fasting | 1 | 2015 | 307 | 0.110 |
Why?
|
| Xenopus | 1 | 2014 | 115 | 0.110 |
Why?
|
| Xenopus Proteins | 1 | 2014 | 60 | 0.110 |
Why?
|
| Xenopus laevis | 1 | 2014 | 129 | 0.110 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 549 | 0.110 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2014 | 126 | 0.110 |
Why?
|
| Physicians | 1 | 2020 | 638 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 732 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2007 | 673 | 0.110 |
Why?
|
| Receptors, Prolactin | 1 | 2013 | 12 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1418 | 0.100 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2015 | 102 | 0.100 |
Why?
|
| Fragile X Syndrome | 1 | 2014 | 155 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2024 | 6589 | 0.100 |
Why?
|
| Hemochromatosis Protein | 2 | 2005 | 23 | 0.100 |
Why?
|
| CHO Cells | 3 | 1999 | 167 | 0.100 |
Why?
|
| Brachydactyly | 1 | 2012 | 10 | 0.100 |
Why?
|
| Oscillometry | 1 | 2012 | 15 | 0.100 |
Why?
|
| Cricetinae | 3 | 1999 | 398 | 0.100 |
Why?
|
| CLOCK Proteins | 1 | 2012 | 31 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 212 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2017 | 812 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2012 | 90 | 0.100 |
Why?
|
| DNA Primers | 3 | 2013 | 669 | 0.100 |
Why?
|
| CpG Islands | 2 | 2011 | 347 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 455 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2015 | 355 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 392 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2016 | 733 | 0.090 |
Why?
|
| Diabetes, Gestational | 1 | 2013 | 115 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 959 | 0.090 |
Why?
|
| Expressed Sequence Tags | 2 | 2001 | 83 | 0.090 |
Why?
|
| Recombinant Proteins | 6 | 2015 | 1439 | 0.090 |
Why?
|
| Mutation, Missense | 4 | 2019 | 931 | 0.090 |
Why?
|
| Satiety Response | 1 | 2010 | 31 | 0.090 |
Why?
|
| Attitude to Health | 1 | 2012 | 262 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2012 | 223 | 0.080 |
Why?
|
| Amino Acids | 2 | 2023 | 687 | 0.080 |
Why?
|
| Blood Glucose | 1 | 2014 | 1194 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2165 | 0.080 |
Why?
|
| Cell Survival | 1 | 1992 | 889 | 0.080 |
Why?
|
| Microarray Analysis | 1 | 2010 | 239 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 1997 | 1850 | 0.080 |
Why?
|
| Prenatal Diagnosis | 1 | 2014 | 629 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2021 | 1973 | 0.080 |
Why?
|
| Mitochondrial Proteins | 2 | 2023 | 243 | 0.080 |
Why?
|
| Bipolar Disorder | 1 | 2013 | 367 | 0.080 |
Why?
|
| Machine Learning | 2 | 2025 | 335 | 0.080 |
Why?
|
| Litter Size | 1 | 2009 | 25 | 0.080 |
Why?
|
| Mice, Congenic | 1 | 2008 | 16 | 0.080 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 170 | 0.080 |
Why?
|
| Arachidonate 12-Lipoxygenase | 2 | 1998 | 5 | 0.070 |
Why?
|
| Pregnancy | 4 | 2021 | 7533 | 0.070 |
Why?
|
| trans-Golgi Network | 1 | 2008 | 7 | 0.070 |
Why?
|
| Citrulline | 2 | 2023 | 114 | 0.070 |
Why?
|
| Molecular Probe Techniques | 1 | 2008 | 23 | 0.070 |
Why?
|
| Hearing Loss | 1 | 2010 | 214 | 0.070 |
Why?
|
| Radiography | 1 | 2010 | 825 | 0.070 |
Why?
|
| Selection, Genetic | 1 | 2008 | 168 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2008 | 105 | 0.070 |
Why?
|
| COS Cells | 1 | 2008 | 283 | 0.070 |
Why?
|
| Degenerin Sodium Channels | 1 | 2007 | 3 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2010 | 814 | 0.070 |
Why?
|
| Acid Sensing Ion Channels | 1 | 2007 | 5 | 0.070 |
Why?
|
| Epithelial Sodium Channels | 1 | 2007 | 16 | 0.070 |
Why?
|
| Sheep | 1 | 2008 | 237 | 0.070 |
Why?
|
| Transgenes | 1 | 2008 | 346 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 7194 | 0.070 |
Why?
|
| Gene Targeting | 1 | 2008 | 185 | 0.070 |
Why?
|
| Oxidoreductases | 2 | 2018 | 103 | 0.070 |
Why?
|
| Spleen | 1 | 2008 | 291 | 0.070 |
Why?
|
| Multigene Family | 1 | 2008 | 324 | 0.070 |
Why?
|
| Kinetics | 4 | 1997 | 1356 | 0.070 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2007 | 73 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 3088 | 0.070 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 183 | 0.070 |
Why?
|
| Protein Transport | 1 | 2008 | 388 | 0.070 |
Why?
|
| Cloning, Molecular | 4 | 2001 | 911 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2007 | 397 | 0.060 |
Why?
|
| Language Development Disorders | 1 | 2008 | 179 | 0.060 |
Why?
|
| Anxiety | 1 | 2013 | 991 | 0.060 |
Why?
|
| Hepatocytes | 2 | 2018 | 241 | 0.060 |
Why?
|
| United States | 2 | 2019 | 11709 | 0.060 |
Why?
|
| Prognosis | 2 | 2020 | 5073 | 0.060 |
Why?
|
| DNA Polymerase gamma | 1 | 2025 | 20 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2007 | 451 | 0.060 |
Why?
|
| Linear Models | 2 | 2018 | 723 | 0.060 |
Why?
|
| Pantothenic Acid | 1 | 2025 | 6 | 0.060 |
Why?
|
| Thioctic Acid | 1 | 2025 | 10 | 0.060 |
Why?
|
| Biotin | 1 | 2025 | 48 | 0.060 |
Why?
|
| Michigan | 1 | 2005 | 53 | 0.060 |
Why?
|
| Parents | 1 | 2012 | 1064 | 0.060 |
Why?
|
| Disease Management | 2 | 2019 | 564 | 0.060 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2025 | 43 | 0.060 |
Why?
|
| Genes, Dominant | 1 | 2005 | 253 | 0.060 |
Why?
|
| Models, Molecular | 1 | 2008 | 1144 | 0.060 |
Why?
|
| Hunger | 1 | 2024 | 43 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2014 | 645 | 0.060 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2005 | 71 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 589 | 0.050 |
Why?
|
| Waist Circumference | 1 | 2024 | 95 | 0.050 |
Why?
|
| Transcriptome | 2 | 2021 | 1136 | 0.050 |
Why?
|
| Gene Amplification | 1 | 2005 | 247 | 0.050 |
Why?
|
| Nitric Oxide Donors | 1 | 2023 | 21 | 0.050 |
Why?
|
| Hedgehog Proteins | 1 | 2005 | 266 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2025 | 242 | 0.050 |
Why?
|
| DNA, Complementary | 3 | 1999 | 471 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2005 | 395 | 0.050 |
Why?
|
| Computational Biology | 1 | 2009 | 887 | 0.050 |
Why?
|
| Fetus | 2 | 2014 | 599 | 0.050 |
Why?
|
| Sex Factors | 1 | 2007 | 1384 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2024 | 174 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2005 | 777 | 0.050 |
Why?
|
| Dilatation | 1 | 2023 | 71 | 0.050 |
Why?
|
| Time Factors | 3 | 2018 | 6585 | 0.050 |
Why?
|
| Dysarthria | 1 | 2022 | 25 | 0.050 |
Why?
|
| Glutathione | 1 | 2023 | 201 | 0.050 |
Why?
|
| Family Health | 1 | 2003 | 268 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2022 | 149 | 0.050 |
Why?
|
| Etoposide | 3 | 1997 | 120 | 0.050 |
Why?
|
| Paraplegia | 1 | 2022 | 92 | 0.050 |
Why?
|
| Nitrogen | 1 | 2022 | 148 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2021 | 2025 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2021 | 46 | 0.050 |
Why?
|
| Chromosome Banding | 2 | 1999 | 140 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2024 | 13001 | 0.050 |
Why?
|
| Benzofurans | 1 | 2021 | 24 | 0.050 |
Why?
|
| Body Composition | 1 | 2024 | 557 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2022 | 91 | 0.050 |
Why?
|
| West Indies | 1 | 2020 | 6 | 0.040 |
Why?
|
| Cyclopropanes | 1 | 2021 | 70 | 0.040 |
Why?
|
| Computer Graphics | 1 | 2021 | 39 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 1161 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2021 | 110 | 0.040 |
Why?
|
| Time | 1 | 2021 | 101 | 0.040 |
Why?
|
| Automation | 1 | 2020 | 62 | 0.040 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2001 | 57 | 0.040 |
Why?
|
| Supratentorial Neoplasms | 1 | 2001 | 40 | 0.040 |
Why?
|
| Chromosome Breakage | 1 | 2001 | 167 | 0.040 |
Why?
|
| Protein Interaction Mapping | 1 | 2020 | 94 | 0.040 |
Why?
|
| Weight Loss | 1 | 2024 | 516 | 0.040 |
Why?
|
| Thymidine | 1 | 2020 | 55 | 0.040 |
Why?
|
| Esophageal Motility Disorders | 1 | 2020 | 20 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2021 | 330 | 0.040 |
Why?
|
| Sequence Tagged Sites | 1 | 2000 | 27 | 0.040 |
Why?
|
| Consensus | 1 | 2024 | 738 | 0.040 |
Why?
|
| COP9 Signalosome Complex | 1 | 1999 | 13 | 0.040 |
Why?
|
| Amsacrine | 2 | 1997 | 5 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2003 | 789 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2021 | 152 | 0.040 |
Why?
|
| Genistein | 2 | 1997 | 40 | 0.040 |
Why?
|
| DNA Damage | 2 | 1994 | 545 | 0.040 |
Why?
|
| Luciferases | 1 | 1999 | 137 | 0.040 |
Why?
|
| Fingers | 1 | 2020 | 68 | 0.040 |
Why?
|
| Hypercholesterolemia | 1 | 2002 | 236 | 0.040 |
Why?
|
| Electron Transport Complex IV | 1 | 2019 | 41 | 0.040 |
Why?
|
| Electron Transport | 1 | 2019 | 56 | 0.040 |
Why?
|
| Isoflavones | 2 | 1997 | 45 | 0.040 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2019 | 7 | 0.040 |
Why?
|
| Mammals | 1 | 2020 | 280 | 0.040 |
Why?
|
| Transcription Factor 4 | 1 | 2019 | 12 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 605 | 0.040 |
Why?
|
| Peroxisomes | 1 | 2019 | 42 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1999 | 802 | 0.040 |
Why?
|
| Clinical Chemistry Tests | 1 | 2018 | 5 | 0.040 |
Why?
|
| Fever | 1 | 2021 | 311 | 0.040 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2018 | 8 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 231 | 0.040 |
Why?
|
| Consanguinity | 1 | 2019 | 118 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2020 | 274 | 0.040 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2020 | 138 | 0.040 |
Why?
|
| Muscles | 1 | 2019 | 306 | 0.040 |
Why?
|
| Coenzymes | 1 | 2018 | 11 | 0.040 |
Why?
|
| Chromatin | 1 | 2022 | 612 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 157 | 0.040 |
Why?
|
| Pseudogenes | 1 | 1998 | 53 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 315 | 0.040 |
Why?
|
| Lymphocytes | 1 | 1999 | 441 | 0.040 |
Why?
|
| Epidermis | 1 | 1998 | 66 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1995 | 328 | 0.030 |
Why?
|
| Ataxia Telangiectasia | 1 | 1997 | 16 | 0.030 |
Why?
|
| DEAD Box Protein 58 | 1 | 2017 | 12 | 0.030 |
Why?
|
| Otitis | 1 | 2017 | 11 | 0.030 |
Why?
|
| Blotting, Western | 1 | 1999 | 1134 | 0.030 |
Why?
|
| Suppression, Genetic | 1 | 1997 | 43 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1997 | 47 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1660 | 0.030 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2017 | 14 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 319 | 0.030 |
Why?
|
| Plasmids | 1 | 2018 | 527 | 0.030 |
Why?
|
| Citric Acid | 1 | 2017 | 38 | 0.030 |
Why?
|
| NF-kappa B | 1 | 1999 | 482 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 364 | 0.030 |
Why?
|
| Gestational Age | 1 | 2021 | 1216 | 0.030 |
Why?
|
| Nitrobenzoates | 1 | 2016 | 7 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 1339 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 1997 | 68 | 0.030 |
Why?
|
| Cyclohexanones | 1 | 2016 | 19 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2020 | 570 | 0.030 |
Why?
|
| Cerebellar Neoplasms | 1 | 2001 | 460 | 0.030 |
Why?
|
| Hydrolases | 1 | 2016 | 61 | 0.030 |
Why?
|
| Plasma | 1 | 2017 | 104 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2017 | 126 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1997 | 320 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2016 | 321 | 0.030 |
Why?
|
| Homologous Recombination | 1 | 2016 | 100 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 704 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 1995 | 36 | 0.030 |
Why?
|
| Medulloblastoma | 1 | 2001 | 569 | 0.030 |
Why?
|
| Sinusitis | 1 | 2017 | 116 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2015 | 89 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2017 | 199 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 624 | 0.030 |
Why?
|
| Drug Resistance, Microbial | 1 | 1995 | 198 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1308 | 0.030 |
Why?
|
| Endophenotypes | 1 | 2015 | 13 | 0.030 |
Why?
|
| Genetic Markers | 1 | 1997 | 631 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 1995 | 221 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 678 | 0.030 |
Why?
|
| Metoclopramide | 1 | 1994 | 10 | 0.030 |
Why?
|
| Argininosuccinate Synthase | 1 | 2014 | 25 | 0.030 |
Why?
|
| Facial Bones | 1 | 2014 | 27 | 0.030 |
Why?
|
| DNA Replication | 1 | 2016 | 363 | 0.030 |
Why?
|
| Chondrogenesis | 1 | 2014 | 29 | 0.030 |
Why?
|
| Drug Resistance | 1 | 1995 | 264 | 0.030 |
Why?
|
| Neural Crest | 1 | 2014 | 56 | 0.030 |
Why?
|
| Tretinoin | 1 | 2014 | 118 | 0.030 |
Why?
|
| Binding Sites | 1 | 1997 | 1377 | 0.030 |
Why?
|
| Hypoglycemia | 1 | 2015 | 193 | 0.030 |
Why?
|
| Ileum | 1 | 1994 | 136 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2001 | 1145 | 0.030 |
Why?
|
| Benzamides | 1 | 1994 | 125 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2014 | 300 | 0.030 |
Why?
|
| Chile | 1 | 2013 | 26 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 608 | 0.030 |
Why?
|
| Pneumonia | 1 | 2017 | 343 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 902 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 1993 | 198 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 396 | 0.030 |
Why?
|
| Amniotic Fluid | 1 | 2014 | 154 | 0.030 |
Why?
|
| Cell Death | 1 | 1993 | 252 | 0.020 |
Why?
|
| Skull | 1 | 2014 | 146 | 0.020 |
Why?
|
| NAV1.3 Voltage-Gated Sodium Channel | 1 | 2012 | 3 | 0.020 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2012 | 14 | 0.020 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2013 | 176 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 3754 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2015 | 701 | 0.020 |
Why?
|
| Cattle | 1 | 1993 | 587 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 1487 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1993 | 612 | 0.020 |
Why?
|
| Age Factors | 1 | 2019 | 2989 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2012 | 109 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 610 | 0.020 |
Why?
|
| Chromosome Duplication | 1 | 2012 | 148 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 1186 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 1992 | 123 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 1997 | 837 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1495 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 917 | 0.020 |
Why?
|
| Neurons | 2 | 2017 | 2041 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 1154 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1995 | 1027 | 0.020 |
Why?
|
| Zebrafish | 1 | 2012 | 419 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 1046 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2554 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 38 | 0.020 |
Why?
|
| Trinucleotide Repeats | 1 | 2006 | 110 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 1868 | 0.010 |
Why?
|
| Iodine Radioisotopes | 2 | 1995 | 79 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2002 | 49 | 0.010 |
Why?
|
| Triglycerides | 1 | 2002 | 614 | 0.010 |
Why?
|
| 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 1 | 1998 | 1 | 0.010 |
Why?
|
| Cholesterol | 1 | 2002 | 573 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 497 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2002 | 604 | 0.010 |
Why?
|
| X-Rays | 1 | 1997 | 30 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1997 | 74 | 0.010 |
Why?
|
| Introns | 1 | 1998 | 316 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1997 | 220 | 0.010 |
Why?
|
| Phylogeny | 1 | 1998 | 786 | 0.010 |
Why?
|
| Receptors, Interleukin-8B | 1 | 1995 | 15 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1995 | 194 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2002 | 1713 | 0.010 |
Why?
|
| Genes, Fungal | 1 | 1995 | 64 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1995 | 139 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 184 | 0.010 |
Why?
|
| Tryptophan | 1 | 1995 | 100 | 0.010 |
Why?
|
| Chemokines | 1 | 1995 | 138 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1997 | 537 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1995 | 218 | 0.010 |
Why?
|
| Species Specificity | 1 | 1995 | 569 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 1994 | 53 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1994 | 171 | 0.010 |
Why?
|
| Models, Structural | 1 | 1994 | 50 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1994 | 87 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1994 | 138 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1994 | 195 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1994 | 261 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1994 | 992 | 0.010 |
Why?
|
| Trichloroacetic Acid | 1 | 1992 | 5 | 0.010 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1992 | 17 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1992 | 158 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 236 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 311 | 0.010 |
Why?
|
| Rabbits | 1 | 1992 | 729 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1994 | 1735 | 0.010 |
Why?
|
| Apoptosis | 1 | 1997 | 1928 | 0.010 |
Why?
|
| Rats | 1 | 1992 | 3882 | 0.000 |
Why?
|